Prescribing Together

What if, rather than being dispensers of medication, mental health clinicians and primary care clinicians treating mental disorders were collaborators with patients in the prescribing relationship? To prescribe more effectively and to achieve health equity, Warren Kinghorn and Abraham Nussbaum argue, it's necessary--and in Prescribing Together, they offer a roadmap for making it a reality. In these pages, readers will find practical introductions to key concepts, from cultural formation and structural competency to collaborative deprescribing, and profiles, enlivened by personal anecdotes, of a diverse group of accomplished clinicians that offer evidence-based strategies for building strong alliances in the context of 13 mental disorder categories, including generalized anxiety disorder, major depressive disorder, borderline personality disorder, and neurocognitive disorders. By focusing on how, rather than what, to prescribe, this book makes room for patients' lived experiences and interpersonal and social contexts, returning to them a sense of agency and empowering them to set meaningful goals and to be active participants in their own flourishing.

Prescribing Mental Health Medication is a text for practitioners who treat mental disorders with medication. It explains the entire process of medication assessment, management and follow up for general medical practitioners, mental health practitioners, students, residents, prescribing nurses and others perfecting this skill. Already used by providers and training institutions throughout the world, the newly revised second edition is completely updated and focuses on the following key issues: How to determine if medication is needed Proper dosing and how to start and stop medication When to change medication Dealing with difficult patients Specific mental health symptoms and appropriate medication Special populations including pregnant women, substance abusers, children and adolescents, and the elderly Monitoring medication with blood levels Management of medication side effects and avoidance of medication risk The misuse of medication Prescription of generic preparations Prescriptions via the Internet, telemedicine, and electronic medical records Organizing a prescriptive office and record-keeping Completely updated, this text includes information on all psychotropic medications in use in the United States and the United Kingdom. It incorporates clinical tips, sample dialogues for talking about medications to patients, and information specifically relevant in primary care settings.

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.

The opioid crisis in the United States has come about because of excessive use of these drugs for both legal and illicit purposes and unprecedented levels of consequent opioid use disorder (OUD). More than 2 million people in the United States are estimated to have OUD, which is caused by prolonged use of prescription opioids, heroin, or other illicit opioids. OUD is a life-threatening condition associated with a 20-fold greater risk of early death due to overdose, infectious diseases, trauma, and suicide. Mortality related to OUD continues to escalate as this public health crisis gathers momentum across the country, with opioid overdoses killing more than 47,000 people in 2017 in the United States. Efforts to date have made no real headway in stemming this crisis, in large part because tools that already existâ€"like evidence-based medicationsâ€"are not being deployed to maximum impact. To support the dissemination of accurate patient-focused information about treatments for addiction, and to help provide scientific solutions to the current opioid crisis, this report studies the evidence base on medication assisted treatment (MAT) for OUD. It examines available evidence on the range of parameters and circumstances in which MAT can be effectively delivered and identifies additional research needed.

"Most books about psychopharmacology focus heavily on the basic science involved and describe the currently available medications, including brief rationales for their use as well as their dosages and their side effects. Others are more for the general public, intended to help them understand how psychopharmacology might be helpful. This book is different. The goal is to teach the reader what medicines are available and what their characteristics are as well as teach very valuable skills: how to think thoroughly and methodically when assessing a patient, when reviewing research data (both basic and clinical), and when thinking through, developing, and monitoring the most effective clinical recommendations for patients. Rather than a lesson in elementary patient assessment, this book is an attempt to help readers identify weaknesses in their practice style and improve them where psychopharmacology is involved"--

Our remedies are only as good as the way in which we dispense them. That is the central premise of Thinking About Prescribing. In this new, thought-provoking volume, more than two dozen experts make the case for an ongoing alliance between pharmacotherapists, young patients, and their families. Chapters tackle issues ranging from the psychodynamics of medication use in youth with serious mental illness, adapting evidence-based motivation and therapy techniques to enhance adherence, cultivating the synergistic role of primary care providers and psychotherapists, engaging in psychoeducation with patients, to prescribing via telemedicine. Readers will pick up the foundational knowledge they need to develop a partnership with patients that is based on trust and candid communication--rather than on just the cold facts about psychotropic medications. Chapters feature key takeaways that distill the most salient points, helping readers to reference--and retain--the information easily.

The opioid overdose epidemic combined with the need to reduce the burden of acute pain poses a public health challenge. To address how evidence-based clinical practice guidelines for prescribing opioids for acute pain might help meet this challenge, Framing Opioid Prescribing Guidelines for Acute Pain: Developing the Evidence develops a framework to evaluate existing clinical practice guidelines for prescribing opioids for acute pain indications, recommends indications for which new evidence-based guidelines should be developed, and recommends a future research agenda to inform and enable specialty organizations to develop and disseminate evidence-based clinical practice guidelines for prescribing opioids to treat acute pain indications. The recommendations of this study will assist professional societies, health care organizations, and local, state, and national agencies to develop clinical practice guidelines for opioid prescribing for acute pain. Such a framework could inform the development of opioid prescribing guidelines and ensure systematic and standardized methods for evaluating evidence, translating knowledge, and formulating recommendations for practice.

Nurse Prescribing in Mental health is a practical handbook for mental health nurses who are being training, have aspirations to train or who are trained in nurse prescribing. It introduces the reader to the different types of nurse prescribing and how they can be used in practice, now and in the future and reflects on the myriad of issues that are facing novice and experienced nurse prescribers. These include inter-professional relationships, team work, ethical and legal issues, governance and patient safety. The text goes on to explore the different types of medicines commonly prescribed for major disease groups and will help nurse prescribers to understand the practical application of prescribing as seen in clinical practice. Key features: Outlines the principles of prescribing and pharmacology as applied to mental health nursing Running through all of the chapters is a review of relevant nurse prescribing research and evidence that supports general prescribing practice with a direct application to clinical practice in mental health settings. Evidenced based Accessible, with case studies and scenarios in each chapter

The Unofficial Guide to Prescribing lays out the practical steps of how to assess, investigate and manage a patient, with a focus on what to prescribe and how to prescribe it. Its aim is to empower newly graduated junior doctors to excel at dealing with emergencies and handling complex prescribing scenarios. Prescribing errors cost healthcare systems millions annually, so early training in prescribing has become an urgent priority of medical education and now forms an essential part of teaching and assessment. The Unofficial Guide to Prescribing (from the same stable as The Unofficial Guide to Passing OSCEs) is a new book designed to address this requirement. It is written by junior doctors still close to the transition from theory to practice, overseen by a review panel of senior clinicians to ensure accuracy, and designed to help medical students practise and learn as much as possible about prescribing, in actual clinical scenarios, before they have to do it for real. Each scenario is presented as you would see it in the hospital setting and covers: Initial step-by-step assessment of the patient: how to assess, assessment findings, and immediate management Initial investigations Initial management Reassessment Treatment Handing over the patient 'Prescribe' alerts throughout Written-up drug charts Blank drug charts for copying and practice

The Model Rules of Professional Conduct provides an up-to-date resource for information on legal ethics. Federal, state and local courts in all jurisdictions look to the Rules for guidance in solving lawyer malpractice cases, disciplinary actions, disqualification issues, sanctions questions and much more. In this volume, black-letter Rules of Professional Conduct are followed by numbered Comments that explain each Rule's purpose and provide suggestions for its practical application. The Rules will help you identify proper conduct in a variety of given situations, review those instances where discretionary action is possible, and define the nature of the relationship between you and your clients, colleagues and the courts.